Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine?

Neuropsychiatric Disease and Treatment

Volumn 7, Issue 1, 2011, Pages 357-364

  Hilburn, Craig ^a   Nejtek, Vicki A ^a   Underwood, Wendy A ^a   Singh, Meharvan ^a   Patel, Gauravkumar ^a   Gangwani, Pooja ^a   Forster, Michael J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Alcohol; BDNF; Cocaine; Craving; Methamphetamine

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT;

ADDICTION; ADULT; AGE DISTRIBUTION; AGED; ALCOHOLISM; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SELF REPORT; SEX DIFFERENCE; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME; YEARS OF CHRONIC SUBSTANCE ABUSE;

EID: 80053651519     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol. 2005;5(1):9-19.
2. Cameron DL, Williams JT. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci. 1994;14(11 Pt 1):6763-6767.
3. Lallemant AM, Bralet J. The effect of cocaine treatment on the level of dopamine and serotonin regeneration and on the level of acetylcholine in rat brain. C R Seances Soc Biol Fil. 1976;170(5):1056-1063.
4. Torre E, Bogetto F. Alcohol and neurotransmitters. Review of literature and experimental research. Minerva Psichiatr. 1981;22(1):7-12.
5. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
6. Lu L, Grimm JW, Shaham Y, Hope BT. Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem. 2003;85(6):1604-1613.
7. Berton O, McClung CA, Dileone RJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006; 311(5672):864-868.
8. Dluzen DE, Story GM, Xu K, Kucera J, Walro JM. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp Neurol. 1999;160(2):500-507.
9. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33(1):73-83.
10. Matsushita S, Kimura M, Miyakawa T, et al. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin Exp Res. 2004;28(11):1609-1612.
11. Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350(6315): 230-232.
12. Pang PT, Lu B. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res Rev. 2004;3(4):407-430.
13. Lu B. BDNF and activity-dependent synaptic modulation. Learn Mem. 2003;10(2):86-98.
14. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci. 2007;10(8):1029-1037.
15. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci. 2004;24(7):1604-1611.
16. Huang MC, Chen CH, Chen CH, et al. Alterations of serum brainderived neurotrophic factor levels in early alcohol withdrawal. Alcohol. 2008;43(3):241-245.
17. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3):261-264.
18. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.
19. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006;83(3):233-237.
20. Tiffany ST, Singleton E, Haertzen CA, Henningfield JE. The development of a cocaine craving questionnaire. Drug Alcohol Depend. 1993; 34(1):19-28.
21. Nejtek VA, Avila M, Chen LA, et al. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry. 2008;69(8): 1257-1266.
22. Brown ES, Nejtek VA, Perantie DC, Rajan Thomas N, Rush AJ. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol. 2003;23(4):384-388.
23. Jockers-Scherubl MC, Danker-Hopfe H, Mahlberg R, et al. Brainderived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett. 2004;371(1):79-83.
24. de Oliveira GS, Cereser KM, Fernandes BS, et al. Decreased brainderived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res. 2009;43(14):1171-1174.
25. Aydemir C, Yalcin ES, Aksaray S, et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(7):1256-1260.
26. Angelucci F, Ricci V, Pomponi M, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol. 2007;21(8):820-825.
27. Post RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res. 2007;41:979-990.
28. Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Katsuki A, Hayashi K, et al. Brain-derived neurotrophic factor (BDNF) and mood disorder. Nihon Shinkei Seishin Yakurigaku Zasshi. 2010;30(5-6):181-184.
29. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci. 2010;64(4):341-357.
30. Nakagawa T, Tsuchida A, Itakura Y, et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes. 2000;49(3):436-444.
31. Pierce RC, Bari AA. The role of neurotrophic factors in psychostimulant- induced behavioral and neuronal plasticity. Rev Neurosci. 2001;12(2):95-110.
32. Bolanos CA, Nestler EJ. Neurotrophic mechanisms in drug addiction. Neuromolecular Med. 2004;5(1):69-83.
33. Cheng CY, Hong CJ, Yu YW, Chen TJ, Wu HC, Tsai SJ. Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res. 2005; 140(1-2):86-90.
34. Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189(5):865-870.
35. Gass P, Hellweg R. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders? Int J Neuropsychopharmacol. 2010;13(1):1-4.
36. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89-131.
37. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37(12):1553-1561.